Is telomerase a viable target in cancer?
- 1 February 2012
- journal article
- review article
- Published by Elsevier BV in Mutation research. Reviews in mutation research
- Vol. 730 (1-2), 90-97
- https://doi.org/10.1016/j.mrfmmm.2011.07.006
Abstract
No abstract availableKeywords
This publication has 135 references indexed in Scilit:
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid TumorsMolecular Therapy, 2010
- Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal disseminationCancer Gene Therapy, 2009
- Telomere length regulation: coupling DNA end processing to feedback regulation of telomeraseThe EMBO Journal, 2009
- How Shelterin Protects Mammalian TelomeresAnnual Review of Genetics, 2008
- Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivoLeukemia, 2008
- Prospects and challenges of building a cancer vaccine targeting telomeraseBiochimie, 2008
- Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II studyBritish Journal of Cancer, 2006
- A DNA damage checkpoint response in telomere-initiated senescenceNature, 2003
- The Hallmarks of CancerCell, 2000
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994